Patient population for bioequivalence study [Regulatives / Guidelines]

posted by pash413 – India, 2017-10-06 17:33 (2825 d 22:11 ago) – Posting: # 17867
Views: 3,937

Dear David
Thanks for the reply.
We are talking about the generic drug with PK endpoint study submission.

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,680 registered users;
41 visitors (0 registered, 41 guests [including 11 identified bots]).
Forum time: 15:45 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5